Detalles de la búsqueda
1.
Angiogenesis inhibition in lung cancer: emerging novel strategies.
Curr Opin Oncol
; 34(1): 107-114, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34812193
2.
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.
Lancet Oncol
; 15(7): 713-21, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24831979
3.
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
Eur J Cancer
; 195: 113404, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37948842
4.
Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
Ther Adv Med Oncol
; 10: 1758835918762094, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29662546
5.
High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
J Clin Oncol
; 21(23): 4423-7, 2003 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14581441
Resultados
1 -
5
de 5
1
Próxima >
>>